Company Overview
Oligmed is a technology-intensive bio-startup developing advanced ingredients for FSMP and Nutraceuticals based on Industry-Academic-Research collaboration.
Since 2025, we have focused on addressing critical health challenges, including appetite regulation, muscle vitality, pain management, and cognitive care through science-based natural solutions.
Ingredients Development
Leadership & Team
Innovators creating results through specialized expertise.
Kim Woo-jin
CEO / Founder
Associate Professor, Dept. of Physiology, KHU
College of Korean Medicine
MD (Doctor of Korean Medicine), Ph.D.
Park Keun-tae
Team Leader
Research Professor,
Dept. of Physiology, KHU
Jeon Yong-jae
Researcher
Research Assistant,
Dept. of Physiology, KHU
Jo Hee-jun
Researcher
Research Assistant,
Dept. of Physiology, KHU
Lee JaeChul
Researcher
Ph.D Candidate, KHU
M.E., KAIST (Innovation and Technology Management)
MD(Doctor of Korean Medicine)
Our Key Pipeline
Oligmed provides optimized targeted nutritional solutions addressing appetite decline, nutrient absorption, and muscle loss.
Bioenhancer
Amino Acids Absorption Increase
OLIM-01 is a bioenhancer that, when taken orally, helps prevent appetite and weight loss while enhancing the absorption of amino acids and peptides.
- Mechanism: Activates key intestinal transporters (PEPT1, ASCT2, BAT1, NHE3).
- Efficacy: Increases circulating levels of essential amino acids, BCAA, and citrulline.
- Benefit: Supports intestinal mucosal recovery and improves overall nutritional status.
Muscle Strength Increasing
Herbal Extract
Developed using AI-based network pharmacology screening to identify key Korean traditional herbal ingredients effective for enhancing muscle strength.
- Process: Optimized hot-water extraction process suitable for commercial production.
- Stability: Completed heat-stability testing to ensure stability throughout distribution.
- Target: Active senior and elderly muscle-function enhancement market.
Our Milestones
Key achievements and ongoing global projects.
Grand Prize at KHU DemoDay
Oligmed, presented by CEO Kim Woo-jin, won the Grand Prize at the startup pitch competition hosted by Kyung Hee University Technology Holdings. We are securing competitiveness in both technology and marketing.
Promotional Video Production
Supported by KHUBI (Kyung Hee Univ. Business Incubator). CEO Kim introduces our vision and solutions for anorexia based on natural product research.
📺 Watch on YouTube
Joint Research Discussion with French Team
Strategic meeting with a French joint research team to discuss new material development. We aim to secure global competitiveness by combining the technological know-how of both parties.
France Expansion: Station F & Exhibitions
Discussing entry into 'Station F', the world's largest startup campus in Paris, and participating in local product exhibitions in November to showcase Oligmed's technology.
MOU with Miraculus (CRO)
Signed an MOU with Miraculus for RWE (Real-World Evidence) based verification. We plan to secure scientific evidence for efficacy and safety to provide reliable product information.
Marketing Partnership with Mega-Influencer
Discussed product promotion with an influencer (760k followers) influential in Korea and SE Asia. This sets the stage for strengthening brand awareness in the Southeast Asian market.
Intellectual Property
Exclusive technology protected by patents and trademarks.
Trademark Application (No. 40-2025-0165152)
Jeung-Saeng-Dam (증생담)
Patent Application (No. 10-2025-0125012)
Method for producing steamed ginger & Poria cocos extract for improving nutrient absorption and its use.